Illumina (ILMN) cash: $1.4B
Illumina held $1.4B in cash and cash equivalents on Dec 28, 2025, up 25.8% from $1.1B a year earlier.
From Illumina's filings with the SEC · Read the filing · ILMN stock page
Illumina cash by year
#395 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 28, 2025 | $1.4B | +26% |
| Dec 29, 2024 | $1.1B | +8% |
| Dec 31, 2023 | $1B | -48% |
| Jan 1, 2023 | $2B | +63% |
| Jan 2, 2022 | $1.2B | – |
Cash of similar companies
Companies in the same industry as Illumina, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| Agilent Technologies | $1.8B | Jan 31, 2026 |
| Illumina | $1.4B | Dec 28, 2025 |
| Revvity | $920M | Dec 28, 2025 |
| Waters | $588M | Dec 31, 2025 |
| Bio-Rad Laboratories | $530M | Dec 31, 2025 |
| 10x Genomics | $474M | Dec 31, 2025 |
| Avantor | $365M | Dec 31, 2025 |
Questions and answers
What is Illumina's cash?
Illumina held $1.4B in cash and cash equivalents on Dec 28, 2025, up 25.8% from $1.1B a year earlier.
Numbers as reported in Illumina's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology